SK
Surendra Kumar Kakkar
About Surendra Kumar Kakkar
Data last updated:
Surendra Kumar Kakkar has 10 years in corporate governance. Holds Director role. Currently with 1 company, including Efficace Pharmaceuticals Private Limited. Engaged in General Business. Contributes to corporate operations. The largest current company by reported revenue is Efficace Pharmaceuticals Private Limited at ₹14.2 Lakh (FY 2025).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Efficace Pharmaceuticals Private Limited U74999DL2016PTC299856 | Director | 17 May 2016 | 2016 | ₹14.2 Lakh (FY 2025) | Active |
Previous companies
Explore Director's current and past company associations Uncover their professional journey today!
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Surendra Kumar Kakkar
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Surendra Kumar Kakkar
Surendra Kumar Kakkar has 10 years in corporate governance. Holds Director role. Currently with 1 company, including Efficace Pharmaceuticals Private Limited. Engaged in General Business. Contributes to corporate operations. The largest current company by reported revenue is Efficace Pharmaceuticals Private Limited at ₹14.2 Lakh (FY 2025).
Surendra Kumar Kakkar is associated with 1 company as Director, including Efficace Pharmaceuticals Private Limited (₹14.2 Lakh).
Surendra Kumar Kakkar has expertise in General Business.
Surendra Kumar Kakkar has 10 years in corporate governance.
By reported revenue, the largest current company of Surendra Kumar Kakkar is Efficace Pharmaceuticals Private Limited, with revenue of ₹14.2 Lakh (FY 2025).
Surendra Kumar Kakkar currently holds positions at 1 company: Efficace Pharmaceuticals Private Limited (₹14.2 Lakh).